{"id":{"repo_id":"cape-town","oai_identifier":"oai:open.uct.ac.za:11427/29483"},"canonical_url":"https://search.dev.ndltd.org/etd/cape-town/oai:open.uct.ac.za:11427/29483","repository":{"repo_id":"cape-town","name":"University of Cape Town","base_url":"https://open.uct.ac.za/oai/request"},"display":{"title":"Prevalence of anxiety disorders among people living with HIV (PLWHIV) and experiencing neuropathic pain who attend clinics in Nkomazi Sub-District","abstract":"Background: Clinical and research experience indicates that a high HIV prevalence setting will have a high occurrence of conditions that are associated with HIV. These conditions are not always infectious in nature. General physiological pain, neuropathic pain (NeuP) and anxiety disorders are conditions that have a high prevalence in people living with HIV (PLWHIV). There is, however, a literature gap on the prevalence of these conditions in Nkomazi Sub-district in South Africa’s Mpumalanga Province. This study therefore aimed to serve as a baseline study for the determination of the prevalence of anxiety disorders and neuropathic pain amongst PLWHIV who attended Highly Active Antiretroviral Therapy (HAART) clinics in Nkomazi Sub-district. Aim of the study: To determine the prevalence of anxiety disorders among PLWHIV with neuropathic pain who attended HAART clinics in Nkomazi sub-district. Objectives of the study: 1) To determine the prevalence of Neuropathic Pain among patients attending HIV clinics in Nkomazi Health District; 2) To determine the prevalence of Anxiety disorders among PLWHIV experiencing neuropathic pain who attended HIV clinics in Nkomazi sub-district. 3) To determine the Types of Anxiety Disorder among Nkomazi PLWHIV with NeuP who have one, or more anxiety disorders. Methods: The objectives were achieved through a cross-sectional study using an interviewer administered questionnaire. Three out of 34 facilities were sampled for the study and participants were recruited and interviewed for a month in April 2013. A total of 508 participants were recruited. The questionnaire was adapted from the Structured Clinical Interview DSM IV Axis I Disorders (Clinicians’ Version) or SCID-CV and the DN4 interview tool for neuropathic pain. The questionnaire also sourced demographic data from all participants. Age is summarised using non-parametric statistics. Categorical variables are summarised using percentages and a bar graph. The Chi-squared and the Fisher’s exact tests are used to compare binary categorical variables. The Prevalence Ratio is the relative measure of association used. The p-value is set at ≤0.05 for statistical significance. The 95% confidence interval (95 =% CI) depicts the precision of estimates. Ethical and access approval were granted by the University of Cape Town Research Ethics Committee and the Mpumalanga Department of Health respectively. Results: Participants were recruited at kaMhlushwa clinic (n = 203 or 39.96%; 95% CI: 35.67 – 44.37), Naas clinic (n = 126 or 24.80%) and Mangweni clinic. There were more females (77.56%; 95% CI: 73.68 – 81.12; n = 394) than males (22.44%; 95% CI: 18.88 – 26.32; n = 114). Pain prevalence was 46.06%; 95% CI: 41.66 – 50.51 (n = 234). The prevalence of neuropathic pain was 17.72%; 95% CI: 14.49 – 21.32 (n = 90) and that of anxiety disorders among those participants with Neuropathic pain was 80%; 95% CI: 70.25 – 87.69 (n = 72). Conclusion: This study confirmed the high prevalence of a complex disease burden in a high HIV prevalent Primary Care setting. The community has high prevalence of pain, anxiety disorders and neuropathic pain amongst PLWHIV patients on HAART.","abstract_html":"Background: Clinical and research experience indicates that a high HIV prevalence setting will have a high occurrence of conditions that are associated with HIV. These conditions are not always infectious in nature. General physiological pain, neuropathic pain (NeuP) and anxiety disorders are conditions that have a high prevalence in people living with HIV (PLWHIV). There is, however, a literature gap on the prevalence of these conditions in Nkomazi Sub-district in South Africa’s Mpumalanga Province. This study therefore aimed to serve as a baseline study for the determination of the prevalence of anxiety disorders and neuropathic pain amongst PLWHIV who attended Highly Active Antiretroviral Therapy (HAART) clinics in Nkomazi Sub-district. Aim of the study: To determine the prevalence of anxiety disorders among PLWHIV with neuropathic pain who attended HAART clinics in Nkomazi sub-district. Objectives of the study: 1) To determine the prevalence of Neuropathic Pain among patients attending HIV clinics in Nkomazi Health District; 2) To determine the prevalence of Anxiety disorders among PLWHIV experiencing neuropathic pain who attended HIV clinics in Nkomazi sub-district. 3) To determine the Types of Anxiety Disorder among Nkomazi PLWHIV with NeuP who have one, or more anxiety disorders. Methods: The objectives were achieved through a cross-sectional study using an interviewer administered questionnaire. Three out of 34 facilities were sampled for the study and participants were recruited and interviewed for a month in April 2013. A total of 508 participants were recruited. The questionnaire was adapted from the Structured Clinical Interview DSM IV Axis I Disorders (Clinicians’ Version) or SCID-CV and the DN4 interview tool for neuropathic pain. The questionnaire also sourced demographic data from all participants. Age is summarised using non-parametric statistics. Categorical variables are summarised using percentages and a bar graph. The Chi-squared and the Fisher’s exact tests are used to compare binary categorical variables. The Prevalence Ratio is the relative measure of association used. The p-value is set at ≤0.05 for statistical significance. The 95% confidence interval (95 =% CI) depicts the precision of estimates. Ethical and access approval were granted by the University of Cape Town Research Ethics Committee and the Mpumalanga Department of Health respectively. Results: Participants were recruited at kaMhlushwa clinic (n = 203 or 39.96%; 95% CI: 35.67 – 44.37), Naas clinic (n = 126 or 24.80%) and Mangweni clinic. There were more females (77.56%; 95% CI: 73.68 – 81.12; n = 394) than males (22.44%; 95% CI: 18.88 – 26.32; n = 114). Pain prevalence was 46.06%; 95% CI: 41.66 – 50.51 (n = 234). The prevalence of neuropathic pain was 17.72%; 95% CI: 14.49 – 21.32 (n = 90) and that of anxiety disorders among those participants with Neuropathic pain was 80%; 95% CI: 70.25 – 87.69 (n = 72). Conclusion: This study confirmed the high prevalence of a complex disease burden in a high HIV prevalent Primary Care setting. The community has high prevalence of pain, anxiety disorders and neuropathic pain amongst PLWHIV patients on HAART.","abstract_has_math":false,"creators":["Ochan, Walter O"],"institution":"Department of Public Health and Family Medicine","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Gwyther, Liz"],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018","date_published":"2018","updated_at":"2026-07-22T22:23:26Z","subjects":[],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/11427/29483","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Gwyther, Liz"]},{"key":"dc:creator","label":"Author","values":["Ochan, Walter O"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2019-02-11T13:35:24Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-02-11T13:35:24Z"]},{"key":"dc:date.issued","label":"Date","values":["2018"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Department of Public Health and Family Medicine"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Cape Town"]},{"key":"dc:type","label":"Dc Type","values":["Master Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Masters"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["MPhil"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11427/29483"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Background: Clinical and research experience indicates that a high HIV prevalence setting will have a high occurrence of conditions that are associated with HIV. These conditions are not always infectious in nature. General physiological pain, neuropathic pain (NeuP) and anxiety disorders are conditions that have a high prevalence in people living with HIV (PLWHIV). There is, however, a literature gap on the prevalence of these conditions in Nkomazi Sub-district in South Africa’s Mpumalanga Province. This study therefore aimed to serve as a baseline study for the determination of the prevalence of anxiety disorders and neuropathic pain amongst PLWHIV who attended Highly Active Antiretroviral Therapy (HAART) clinics in Nkomazi Sub-district. Aim of the study: To determine the prevalence of anxiety disorders among PLWHIV with neuropathic pain who attended HAART clinics in Nkomazi sub-district. Objectives of the study: 1) To determine the prevalence of Neuropathic Pain among patients attending HIV clinics in Nkomazi Health District; 2) To determine the prevalence of Anxiety disorders among PLWHIV experiencing neuropathic pain who attended HIV clinics in Nkomazi sub-district. 3) To determine the Types of Anxiety Disorder among Nkomazi PLWHIV with NeuP who have one, or more anxiety disorders. Methods: The objectives were achieved through a cross-sectional study using an interviewer administered questionnaire. Three out of 34 facilities were sampled for the study and participants were recruited and interviewed for a month in April 2013. A total of 508 participants were recruited. The questionnaire was adapted from the Structured Clinical Interview DSM IV Axis I Disorders (Clinicians’ Version) or SCID-CV and the DN4 interview tool for neuropathic pain. The questionnaire also sourced demographic data from all participants. Age is summarised using non-parametric statistics. Categorical variables are summarised using percentages and a bar graph. The Chi-squared and the Fisher’s exact tests are used to compare binary categorical variables. The Prevalence Ratio is the relative measure of association used. The p-value is set at ≤0.05 for statistical significance. The 95% confidence interval (95 =% CI) depicts the precision of estimates. Ethical and access approval were granted by the University of Cape Town Research Ethics Committee and the Mpumalanga Department of Health respectively. Results: Participants were recruited at kaMhlushwa clinic (n = 203 or 39.96%; 95% CI: 35.67 – 44.37), Naas clinic (n = 126 or 24.80%) and Mangweni clinic. There were more females (77.56%; 95% CI: 73.68 – 81.12; n = 394) than males (22.44%; 95% CI: 18.88 – 26.32; n = 114). Pain prevalence was 46.06%; 95% CI: 41.66 – 50.51 (n = 234). The prevalence of neuropathic pain was 17.72%; 95% CI: 14.49 – 21.32 (n = 90) and that of anxiety disorders among those participants with Neuropathic pain was 80%; 95% CI: 70.25 – 87.69 (n = 72). Conclusion: This study confirmed the high prevalence of a complex disease burden in a high HIV prevalent Primary Care setting. The community has high prevalence of pain, anxiety disorders and neuropathic pain amongst PLWHIV patients on HAART."]},{"key":"dc:title","label":"Title","values":["Prevalence of anxiety disorders among people living with HIV (PLWHIV) and experiencing neuropathic pain who attend clinics in Nkomazi Sub-District"]}]}],"canonical_facts":{"dc:contributor.advisor":["Gwyther, Liz"],"dc:creator":["Ochan, Walter O"],"dc:date.accessioned":["2019-02-11T13:35:24Z"],"dc:date.available":["2019-02-11T13:35:24Z"],"dc:date.issued":["2018"],"dc:description.abstract":["Background: Clinical and research experience indicates that a high HIV prevalence setting will have a high occurrence of conditions that are associated with HIV. These conditions are not always infectious in nature. General physiological pain, neuropathic pain (NeuP) and anxiety disorders are conditions that have a high prevalence in people living with HIV (PLWHIV). There is, however, a literature gap on the prevalence of these conditions in Nkomazi Sub-district in South Africa’s Mpumalanga Province. This study therefore aimed to serve as a baseline study for the determination of the prevalence of anxiety disorders and neuropathic pain amongst PLWHIV who attended Highly Active Antiretroviral Therapy (HAART) clinics in Nkomazi Sub-district. Aim of the study: To determine the prevalence of anxiety disorders among PLWHIV with neuropathic pain who attended HAART clinics in Nkomazi sub-district. Objectives of the study: 1) To determine the prevalence of Neuropathic Pain among patients attending HIV clinics in Nkomazi Health District; 2) To determine the prevalence of Anxiety disorders among PLWHIV experiencing neuropathic pain who attended HIV clinics in Nkomazi sub-district. 3) To determine the Types of Anxiety Disorder among Nkomazi PLWHIV with NeuP who have one, or more anxiety disorders. Methods: The objectives were achieved through a cross-sectional study using an interviewer administered questionnaire. Three out of 34 facilities were sampled for the study and participants were recruited and interviewed for a month in April 2013. A total of 508 participants were recruited. The questionnaire was adapted from the Structured Clinical Interview DSM IV Axis I Disorders (Clinicians’ Version) or SCID-CV and the DN4 interview tool for neuropathic pain. The questionnaire also sourced demographic data from all participants. Age is summarised using non-parametric statistics. Categorical variables are summarised using percentages and a bar graph. The Chi-squared and the Fisher’s exact tests are used to compare binary categorical variables. The Prevalence Ratio is the relative measure of association used. The p-value is set at ≤0.05 for statistical significance. The 95% confidence interval (95 =% CI) depicts the precision of estimates. Ethical and access approval were granted by the University of Cape Town Research Ethics Committee and the Mpumalanga Department of Health respectively. Results: Participants were recruited at kaMhlushwa clinic (n = 203 or 39.96%; 95% CI: 35.67 – 44.37), Naas clinic (n = 126 or 24.80%) and Mangweni clinic. There were more females (77.56%; 95% CI: 73.68 – 81.12; n = 394) than males (22.44%; 95% CI: 18.88 – 26.32; n = 114). Pain prevalence was 46.06%; 95% CI: 41.66 – 50.51 (n = 234). The prevalence of neuropathic pain was 17.72%; 95% CI: 14.49 – 21.32 (n = 90) and that of anxiety disorders among those participants with Neuropathic pain was 80%; 95% CI: 70.25 – 87.69 (n = 72). Conclusion: This study confirmed the high prevalence of a complex disease burden in a high HIV prevalent Primary Care setting. The community has high prevalence of pain, anxiety disorders and neuropathic pain amongst PLWHIV patients on HAART."],"dc:identifier.uri":["http://hdl.handle.net/11427/29483"],"dc:language.iso":["eng"],"dc:publisher.department":["Department of Public Health and Family Medicine"],"dc:publisher.institution":["University of Cape Town"],"dc:title":["Prevalence of anxiety disorders among people living with HIV (PLWHIV) and experiencing neuropathic pain who attend clinics in Nkomazi Sub-District"],"dc:type":["Master Thesis"],"dc:type.qualificationlevel":["Masters"],"dc:type.qualificationname":["MPhil"]},"updated_at":"2026-07-22T22:23:26Z"}